The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Orthofix International met expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue shrank significantly. Non-GAAP earnings per share increased. GAAP earnings per share increased significantly.
Margins increased across the board.
Orthofix International chalked up revenue of $112.0 million. The four analysts polled by S&P Capital IQ looked for a top line of $112.1 million on the same basis. GAAP reported sales were 26% lower than the prior-year quarter's $151.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.81. The six earnings estimates compiled by S&P Capital IQ averaged $0.80 per share. Non-GAAP EPS of $0.81 for Q4 were 1.3% higher than the prior-year quarter's $0.80 per share. GAAP EPS of $1.04 for Q4 were 58% higher than the prior-year quarter's $0.66 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 83.5%, 670 basis points better than the prior-year quarter. Operating margin was 22.1%, 440 basis points better than the prior-year quarter. Net margin was 18.3%, much better than the prior-year quarter.
Next quarter's average estimate for revenue is $115.0 million. On the bottom line, the average EPS estimate is $0.69.
Next year's average estimate for revenue is $476.2 million. The average EPS estimate is $3.04.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 117 members out of 125 rating the stock outperform, and eight members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 38 give Orthofix International a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Orthofix International is outperform, with an average price target of $49.08.
Is Orthofix International the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Orthofix International to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.